Award recordCONTRACT

GILEAD SCIENCES INC

PIID 36C24621F0040· VHA· 246-NETWORK CONTRACTING OFFICE 6 (36C246)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $67,730 net obligations· UEI FPJMGUK1BYH8· CA

Description

EO14042 COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER

First action · last action
2020-10-28 · 2020-12-23
Transactions
2
First transaction's obligation
$46,710
Base + all options value (sum of deltas)
$67,730
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70252
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$67,730$0Base award · 2020-10-28 · this action $46,710 · running total $46,710Modification P00001 · 2020-12-23 · this action $21,020 · running total $67,730
  • Base2020-10-28+$46,710= $46,710
  • Mod P000012020-12-23+$21,020= $67,730
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-10-28+$46,710$46,710EO14042 COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER
Mod P00001· OTHER ADMINISTRATIVE ACTION2020-12-23+$21,020$67,730EO14042 COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FPJMGUK1BYH8)

AwardOffice · PSC / listingNet obligationsFY
36C26125N0499261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$14,894FY2025
36C26025F0137260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$3,103FY2025
36C26025F0134260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$2,482FY2025
36C24524N0911245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,938FY2024
36C26024F0466260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024
36C26024F0440260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024

Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24626N1034PARTNER THERAPEUTICS, INC.246-NETWORK CONTRACTING OFFICE 6 (36C246)$72,362FY2026
36C24626A0027PROGENICS PHARMACEUTICALS INC246-NETWORK CONTRACTING OFFICE 6 (36C246)$0FY2026
36C24626N0890PROGENICS PHARMACEUTICALS INC246-NETWORK CONTRACTING OFFICE 6 (36C246)$1,212,530FY2026
36C24626N0782PARTNER THERAPEUTICS, INC.246-NETWORK CONTRACTING OFFICE 6 (36C246)$72,563FY2026
36C24626N0690PARTNER THERAPEUTICS, INC.246-NETWORK CONTRACTING OFFICE 6 (36C246)$54,422FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24621F0040_3600_V797D70252_3600 · retrieved 2026-09-27.